Revolutionary Anti-Aging Treatment Accelerates Wound Healing
Researchers from Boston University’s School of Medicine have uncovered a groundbreaking topical anti-aging treatment with the potential to transform the process of wound healing in aging skin. The drug, ABT-263, was featured in the journal Aging in May 2026. Its mechanism of action involves the elimination of damaged “senescent cells” – colloquially known as “zombie cells” – that accumulate with age and impede the body’s natural repair processes.
In studies conducted on aged mice, the topical application of ABT-263 yielded impressive results within a short span of five days. By the 24th day post-injury, a significant 80% of mice treated with ABT-263 exhibited fully healed wounds. This was in stark contrast to the mere 56% of untreated mice. Furthermore, the treatment stimulated genes linked to collagen production and tissue regeneration, all without the usual side effects associated with oral senolytic drugs.
The researchers emphasized the potential of topical senolytic treatments to enhance wound healing in aging skin. They stated, “Our study underscores the potential of topical senolytic treatments to enhance wound healing in aging skin, presenting a potentially promising strategy for preoperative care.”
In a follow-up study conducted in 2026, ABT-263 was examined via specialized wound dressing in diabetic mice – a notoriously difficult-to-heal population. The results reported a reduced senescent cell burden with no detectable systemic toxicity. These findings could pave the way for new treatments for slow-healing wounds in older adults, particularly in the areas of post-surgical recovery and chronic wound care.
Source: ScienceDaily